Organogenesis' Grant - II Round

Organogenesis raised a round of funding on February 07, 2012. Investors include Massachusetts Life Sciences Center.

Organogenesis provides wound care products for bio-active wound healing and soft tissue regeneration. The portfolio includes FDA-approved Apligraf and Dermagraft, for bio-active wound healing and laun…

Articles about Organogenesis' Grant - II Round: